NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016

Kenneth C. Anderson; Melissa Alsina; Djordje Atanackovic; Jason C. Chandler; Caitlin Costello; Benjamin Djulbegović; Cristina Gasparetto; Kelly Godby; Craig C. Hofmeister; Leona Holmberg; Sarah A. Holstein; Carol Ann Huff; Adetola A. Kassim; Shaji Kumar; Michaela Liedtke; Matthew A. Lunning; Noopur Raje; Frederic J. Reu; Seema Singhal; George Somlo; Keith Stockerl‐Goldstein; Steven P. Treon; Joachim Yahalom; Dorothy A. Shead; Rashmi Kumar

doi:10.6004/jnccn.2016.0046

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the 2016 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include updated recommendations to the overall management of multiple myeloma from diagnosis and staging to new treatment options.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Anderson et al. (2016) studied this question.

synapsesocial.com/papers/6a852e4399a7c860b242ef1f https://doi.org/10.6004/jnccn.2016.0046

View Full Paper

Ask AI

Bookmark

Share

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016

Ask about this paper

Abstract

Discussion

Cite This Study

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading